BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20251118T000000
DTEND;TZID=America/Sao_Paulo:20251120T000000
DTSTAMP:20260410T001614
CREATED:20241220T185650Z
LAST-MODIFIED:20250607T192445Z
UID:10000109-1763424000-1763596800@oncodaily.com
SUMMARY:ESID-EHA-SIOPE Focused Symposium 2025
DESCRIPTION:ESID-EHA-SIOPE Focused Symposium 2025 will take place in Vienna\, 18-20 November 2025. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe ESID-EHA-SIOPE 2025 symposium will be a landmark event that brings together leading experts from the fields of immunology\, haematology\, and paediatric oncology to explore the critical intersections between these specialties. Titled “The Interplay of Immunology and Haematology” the symposium aims to foster collaboration and discussion on how advancements in each of these areas can improve the diagnosis\, treatment\, and management of patients with complex\, multi-faceted conditions. The event promises an immersive experience where professionals will share their insights and innovative approaches in addressing the evolving challenges in patient care. \nAs patient cases become increasingly intricate\, these specialties are more interconnected than ever before. The symposium will provide a unique platform to explore the complex relationships between immunodeficiencies\, hematologic\, and oncologic conditions\, helping clinicians develop more comprehensive\, multidisciplinary approaches. Participants will have the opportunity to examine pathophysiological links among these fields\, discussing the latest best practices for screening\, integrated treatment\, and patient management. With a focus on driving better patient outcomes through collective expertise\, the event will encourage deep discussions on how collaboration across these fields can enhance patient care and treatment efficacy. \nThe ESID-EHA-SIOPE 2025 symposium will also feature cutting-edge research\, with an emphasis on scientific discovery and its application in clinical practice. Attendees can expect to learn about the latest breakthroughs in immunodeficiencies\, haematology\, and oncology\, and contribute to the growing body of knowledge in these fields. The event is particularly encouraging for fellows\, researchers\, and junior faculty\, offering a platform for them to present and discuss novel basic and clinical information. By uniting experts from three pivotal societies\, this symposium marks a new era of collaboration\, with the shared goal of improving patient outcomes through a multidisciplinary approach to complex health challenges. \nFor Registration\, visit here.\nFor Abstract Submission\, visit here.
URL:https://oncodaily.com/event/209922
LOCATION:Vienna\, Austria\, Vienna\, 1300\, Austria
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/8-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250612T000000
DTEND;TZID=Europe/Helsinki:20250615T000000
DTSTAMP:20260410T001614
CREATED:20241017T181109Z
LAST-MODIFIED:20250607T193501Z
UID:10000044-1749686400-1749945600@oncodaily.com
SUMMARY:EHA 2025 Congress
DESCRIPTION:The 30th EHA Congress is scheduled for June 12-15\, 2025 at Milan Italy. \nIt promises to transform the way we engage with hematology. The EHA team has worked hard to redesign the Congress experience\, incorporating new\, innovative features to enhance your learning journey. \nWith a stronger emphasis on invited speakers and the addition of a second poster session\, the Congress will present the most cutting-edge research in the field. The revised program offers a carefully curated balance of scientific content\, reducing the number of parallel sessions to avoid information overload. \nEHA2025 aims to provide an unforgettable experience\, fostering meaningful connections\, inspiring innovation\, and driving progress in hematology.
URL:https://oncodaily.com/event/166755
LOCATION:Allianz MiCo-Milano Convention Centre\, Piazzale Carlo Magno 1 - 20149 Milano (Lombardia)\, Milan\, 20149\, Italy
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20250425T080000
DTEND;TZID=Europe/Berlin:20250426T170000
DTSTAMP:20260410T001614
CREATED:20250217T131828Z
LAST-MODIFIED:20250607T193825Z
UID:10000146-1745568000-1745686800@oncodaily.com
SUMMARY:EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary sAML
DESCRIPTION:EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary AMLs will be held April 25-26\, 2025 at Berlin\, Germany. \nThe EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias (sAML) will focus on therapy-related AML and AML evolving from previous myeloid diseases\, such as MDS or MFS/MPN. Key topics will include clonal hematopoiesis\, clonal evolution mechanisms\, and special clinical situations. \nThe program will cover pathogenetic mechanisms\, including susceptibility factors like molecular lesions\, the bone marrow microenvironment\, and the impact of drugs. Special topics include sAML following childhood malignancies\, gene therapy\, CAR-T cell therapy\, and AML of donor origin in allogeneic stem cell transplantation. The meeting will feature leading experts in sAML molecular characterization\, disease diagnosis\, management\, and treatment. The event will be chaired by K. Döhner\, P. Vyas\, and M.T. Voso. \nRegistration is open.
URL:https://oncodaily.com/event/244599
LOCATION:Berlin\, Berlin\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/download-2-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250317T000000
DTEND;TZID=Europe/Helsinki:20250320T120000
DTSTAMP:20260410T001614
CREATED:20241017T181011Z
LAST-MODIFIED:20250607T195046Z
UID:10000045-1742169600-1742472000@oncodaily.com
SUMMARY:EHA Research Conference 2025
DESCRIPTION:EHA Research Conference 2025 will be held at Malaga\, Spain from March 17-20. \nEHA is excited to announce the third edition of the EHA Research Conference\, focusing on the theme ‘Transcriptional Control and Chromatin Alterations in Normal and Abnormal Hematopoiesis.’ \nSpanning 3.5 days\, the conference will provide ample time for in-depth discussions\, networking\, and social activities\, fostering collaboration and exchange among participants. The goal of the 2025 meeting is to explore\, synthesize\, and discuss key topics related to transcriptional regulation and chromatin changes in both healthy and diseased hematopoiesis. \nRegistration is open for the event.
URL:https://oncodaily.com/event/166776
LOCATION:Hotel Sol Marbella Estepona Atalaya Park\, Av. de las Golondrinas\, 2\, 29688 Estepona\, Malaga\, 29688\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-11-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250206T000000
DTEND;TZID=Europe/Helsinki:20250208T000000
DTSTAMP:20260410T001614
CREATED:20241025T133412Z
LAST-MODIFIED:20250608T090205Z
UID:10000058-1738800000-1738972800@oncodaily.com
SUMMARY:EHA-EBMT 7th European CAR T-cell Meeting
DESCRIPTION:EHA-EBMT 7th European CAR T-cell Meeting will be held from 6 February 2025 – 8 February 2025\, at Strasbourg\, France. \nThe meeting will cover a broad range of topics in CAR T-cell therapy\, including the latest unpublished clinical data\, advancements in manufacturing\, toxicity modeling\, CAR design\, and delivery methods. Participants will explore novel applications of CAR T-cell therapy and hear from leading experts in the field. It’s an excellent opportunity to stay updated on cutting-edge research and connect with peers and professionals driving innovation in CAR T-cell therapy. \nFor Registration Visit Here.
URL:https://oncodaily.com/event/170129
LOCATION:Palais de la Musique et des Congrès\, Place de Bordeaux\, Strasbourg\, 67000\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/IMG_7459.jpg
END:VEVENT
END:VCALENDAR